Discover
ATNM
Actinium Pharmaceuticals, Inc.
0.79
1 x 0.72
1 x 0.89
bid
ask
+
0.02
2.97%
undefined @ 04:00 PM
0.79 +0.00 (0.00%)
| Ytd | -41.68% | |
| 1y | -46.05% |
0.78
day range
0.82
0.73
52 week range
1.81
| Open | 0.78 | Prev Close | 0.77 | Low | 0.78 | High | 0.82 | Mkt Cap | 24.88M |
| Vol | 0.00 | Avg Vol | 117.48K | EPS | -0.75 | P/E | -1.06 | Forward P/E | -1.77 |
| Beta | 0.15 | Short Ratio | 5.72 | Inst. Own | 30.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-08 | 50-d Avg | 0.96 | 200-d Avg | 1.20 | 1yr Est | 5.00 |
| Income Statement | |||
| Total Revenue | 35.00M | ||
| Revenues (USD) | 35.00M | ||
| Gross Profit | 35.00M | ||
| Operating Expenses | 7.44M | ||
| Research and Development Expense | 5.38M | ||
| Selling, General and Administrative Expense | 2.06M | ||
| Operating Income | 27.57M | ||
| Net Income | 27.90M | ||
| Net Income Common Stock | 27.90M | ||
| Net Income Common Stock (USD) | 27.90M | ||
| Consolidated Income | 27.90M | ||
| Earnings per Basic Share | 0.89 | ||
| Earnings per Basic Share (USD) | 0.89 | ||
| Earnings per Diluted Share | 0.89 | ||
| Earning Before Interest & Taxes (EBIT) | 27.90M | ||
| Earning Before Interest & Taxes (USD) | 27.90M | ||
| Weighted Average Shares | 31.40M | ||
| Weighted Average Shares Diluted | 31.41M | ||
| Balance Sheet | |||
| Cash and Equivalents | 36.47M | ||
| Cash and Equivalents (USD) | 36.47M | ||
| Investments | 339.00K | ||
| Investments Non-Current | 339.00K | ||
| Current Assets | 37.74M | ||
| Property, Plant & Equipment Net | 2.08M | ||
| Total Assets | 40.16M | ||
| Debt Current | 746.00K | ||
| Total Debt | 1.34M | ||
| Current Liabilities | 9.26M | ||
| Debt Non-Current | 595.00K | ||
| Total Liabilities | 9.86M | ||
| Accumulated Retained Earnings (Deficit) | -387.33M | ||
| Accumulated Other Comprehensive Income | -60.00K | ||
| Shareholders Equity | 30.30M | ||
| Shareholders Equity (USD) | 30.30M | ||
| Assets Non-Current | 2.42M | ||
| Total Debt (USD) | 1.34M | ||
| Liabilities Non-Current | 595.00K | ||
| Trade and Non-Trade Payables | 8.51M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 241.00K | ||
| Net Cash Flow from Financing | -2.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.66M | ||
| Capital Expenditure | -478.00K | ||
| Issuance (Repayment) of Debt Securities | -2.00K | ||
| Net Cash Flow from Investing | -478.00K | ||
| Net Cash Flow from Operations | -5.18M | ||
| Effect of Exchange Rate Changes on Cash | 2.00K | ||
| Share Based Compensation | 118.00K | ||